+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

Clinical Nutrition for Cancer Care Global Market Report 2024 - Product Thumbnail Image

Clinical Nutrition for Cancer Care Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
From
Progesterone Market 2024-2028 - Product Thumbnail Image

Progesterone Market 2024-2028

  • Report
  • November 2024
  • 160 Pages
  • Global
From
Womens Health Diagnostics Market 2024-2028 - Product Thumbnail Image

Womens Health Diagnostics Market 2024-2028

  • Report
  • July 2024
  • 189 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market 2024-2028 - Product Thumbnail Image

Breast Cancer Liquid Biopsy Market 2024-2028

  • Report
  • July 2024
  • 141 Pages
  • Global
From
Breast Cancer Liquid Biopsy Testing Devices Market 2024-2028 - Product Thumbnail Image

Breast Cancer Liquid Biopsy Testing Devices Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
HER2 Positive Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2 Positive Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 180 Pages
  • Global
From
From
HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Metastatic HER2 positive breast cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic HER2 positive breast cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
ER positive, HER2 negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

ER positive, HER2 negative Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
From
Advanced ovarian cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced ovarian cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 210 Pages
  • Global
From
Inflammatory Breast Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Inflammatory Breast Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more